At Taiho Pharmaceutical, researchers and departments with knowledge and experience in many specialized fields integrate their diverse abilities to drive in-house drug discovery forward. In addition, the company is expanding its drug-enabling platform technologies and is pursuing external research collaboration in and outside Japan to supplement its own technology and accelerate research and development.
Taiho Pharmaceutical is also pursuing drug discovery in challenging fields and of challenging targets by collaborating and partnering with other companies, including Otsuka group companies.
The company has also been strengthening its drug discovery capabilities by investing in Remiges BioPharma Fund, LP, an open innovation fund, and in promising biotechnology ventures around the world through Taiho Ventures, LLC, a U.S.-based subsidiary.
All this is being done to improve the health of patients worldwide and contribute to a society enriched by smiles. Taiho Pharmaceutical will continue taking on the challenge of researching and developing unique new drugs.